期刊簡介預(yù)計(jì)審稿時(shí)間： 約2.7個(gè)月 約7.5周

International Immunopharmacology is the primary vehicle for the publication of original research papers pertinent to the overlapping areas of immunology, pharmacology, cytokine biology, immunotherapy, immunopathology and immunotoxicology. Review articles that encompass these subjects are also welcome.

The subject material appropriate for submission includes:

? Clinical studies employing immunotherapy of any type including the use of: bacterial and chemical agents; thymic hormones, interferon, lymphokines, etc., in transplantation and diseases such as cancer, immunodeficiency, chronic infection and allergic, inflammatory or autoimmune disorders.

? Studies on the mechanisms of action of these agents for specific parameters of immune competence as well as the overall clinical state.

? Pre-clinical animal studies and in vitro studies on mechanisms of action with immunopotentiators, immunomodulators, immunoadjuvants and other pharmacological agents active on cells participating in immune or allergic responses.

? Pharmacological compounds, microbial products and toxicological agents that affect the lymphoid system, and their mechanisms of action.

? Agents that activate genes or modify transcription and translation within the immune response.

? Substances activated, generated, or released through immunologic or related pathways that are pharmacologically active.

? Production, function and regulation of cytokines and their receptors.

? Classical pharmacological studies on the effects of chemokines and bioactive factors released during immunological reactions.

《國際免疫藥理學(xué)》是發(fā)表與免疫學(xué)、藥理學(xué)、細(xì)胞因子生物學(xué)、免疫療法、免疫病理學(xué)和免疫毒理學(xué)重疊領(lǐng)域相關(guān)的原創(chuàng)研究論文的主要載體。也歡迎涵蓋這些主題的評(píng)論文章。

適合提交的主題材料包括：

? 采用任何類型的免疫療法的臨床研究，包括使用：細(xì)菌和化學(xué)藥劑；胸腺激素、干擾素、淋巴因子等，在移植和癌癥、免疫缺陷、慢性感染和過敏、炎癥或自身免疫性疾病等疾病中的作用。

? 研究這些藥物對免疫能力特定參數(shù)以及整體臨床狀態(tài)的作用機(jī)制。

? 臨床前動(dòng)物研究和體外研究免疫增強(qiáng)劑、免疫調(diào)節(jié)劑、免疫佐劑和其他對參與免疫或過敏反應(yīng)的細(xì)胞有活性的藥劑的作用機(jī)制。

? 影響淋巴系統(tǒng)的藥理化合物、微生物產(chǎn)品和毒理劑及其作用機(jī)制。

? 激活基因或修改免疫反應(yīng)內(nèi)轉(zhuǎn)錄和翻譯的藥劑。

? 通過免疫或相關(guān)途徑激活、生成或釋放的具有藥理活性的物質(zhì)。

? 細(xì)胞因子及其受體。

? 關(guān)于免疫反應(yīng)過程中釋放的趨化因子和生物活性因子作用的經(jīng)典藥理學(xué)研究。

《International Immunopharmacology》(國際免疫藥理學(xué))編輯部通訊方式為ELSEVIER SCIENCE BV, PO BOX 211, AMSTERDAM, NETHERLANDS, 1000 AE。如果您需要協(xié)助投稿或潤稿服務(wù)，您可以咨詢我們的客服老師。我們專注于期刊咨詢服務(wù)十年，熟悉發(fā)表政策，可為您提供一對一投稿指導(dǎo)，避免您在投稿時(shí)頻繁碰壁，節(jié)省您的寶貴時(shí)間，有效提升發(fā)表機(jī)率，確保SCI檢索（檢索不了全額退款）。我們視信譽(yù)為生命，多方面確保文章安全保密，在任何情況下都不會(huì)泄露您的個(gè)人信息或稿件內(nèi)容。